Hoersholm, Denmark, January 24 th , 2017 – Medical Prognosis Institute A/S today announced that its Drug Response Predictor DRP tool was studied as a tool for Personalized Medicine – Patient Response Prediction – PRP . MPI’s vision is to develop a tool in the form of a report over drugs that are most likely to be effective for the individual cancer patient.